Aflibercept exhibits VEGF binding stoichiometry distinct from bevacizumab and does not support formation of immune-like complexes

Douglas A. MacDonald; Joel Martin; Kathir K. Muthusamy; Jiann-Kae Luo; Erica Pyles; Ashique Rafique; Tammy Huang; Terra Potocky; Yang Liu; Jingtai Cao; Françoise Bono; Nathalie Delesque; Pierre Savi; John Francis; Ali Amirkhosravi; Todd Meyer; Carmelo Romano; Meredith Glinka; George D. Yancopoulos; Neil Stahl; Stanley J. Wiegand; Nicholas Papadopoulos